Potassium channel openers prevent β-amyloid toxicity in bovine vascular endothelial cells

Neuroscience Letters

Volumn 290, Issue 1, 2000, Pages 9-12

  Chi, X ^a   Sutton, E T ^a   Hellermann, G ^a   Price, J M ^a  

^a School of Medicine   (United States)

Author keywords

Alzheimer's disease; Amyloid; Endothelial cells; Necrosis; Nitric oxide; Potassium channels

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; AMYLOID BETA PROTEIN; DIAZOXIDE; GLIBENCLAMIDE; NITRIC OXIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; TETRYLAMMONIUM;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; VASCULAR ENDOTHELIUM;

AMYLOID BETA-PROTEIN; ANIMALS; BENZIMIDAZOLES; BRAIN; CATTLE; CELLS, CULTURED; DIAZOXIDE; ENDOTHELIUM, VASCULAR; GLYBURIDE; POTASSIUM CHANNELS; TETRAETHYLAMMONIUM;

EID: 0034683225     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01293-3     Document Type: Article

References (21)

1. Blanc E.M., Toborek M., Mark R.J., Hennig B., Mattson M.P. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68:1997;1870-1880.
2. + channel openers on β-amyloid induced cerebrovascular endothelial dysfunction. Neurol. Res. 21:1999;345-351.
3. Colom L.V., Diaz M.E., Beers D.R., Neely A., Xie W., Appel S.H. Role of potassium channels in amyloid-induced cell death. J. Neurochem. 70:1998;1925-1934.
4. de Silva H.A., Aronson J.K., Grahame-Smith D.G., Jobst K.A., Smith A.D. Abnormal function of potassium channels in platelets of patients with Alzheimer disease. Lancet. 352:1998;1590-1593.
5. + channels. Science. 264:1994;276-279.
6. + channels. Life Sci. 59:1996;491-498.
7. + channels: possible mechanism of cardioprotection. Circ. Res. 81:1997;1072-1082.
8. + channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity. Brain Res. 7706:1996;328-332.
9. Grammas P., Moore P., Weigel P.H. Microvessels from Alzheimer's disease brains kill neurons in vitro. Am. J. Pathol. 154:1999;337-342.
10. Kalaria R.N., Hedera P. β-Amyloid vasoactivity in Alzheimer's disease. Lancet. 347:1996;1492-1493.
11. Li L., Bressler B., Prameya R., Dorovini-Zis K., Van Breemen C. Agonist-stimulated calcium entry in primary cultures of human cerebral microvascular endothelial cells. Microvasc. Res. 57:1999;211-226.
12. Pogrebniak H.W., Mathews W., Pass H.I. Alteration in macrophage free radical and tumor necrosis factor production by a potassium channel activator. J. Surg. Res. 52:1992;395-400.
13. Price J.M., Sutton E.T., Hellermann A., Thomas T. β-Amyloid induces cerebral vascular endothelial dysfunction in rat brain. Neurol. Res. 19:1997;534-538.
14. + channel activation. Eur. J. Pharmacol. 291:1995;217-219.
15. Sargent C.A., Gover G.J., Antonaccio M.J., McCullough J.R. The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004. J. Pharmacol. Exp. Ther. 266:1993;1422-1429.
16. Sutton E.T., Hellermann G.R., Thomas T. β-Amyloid induced endothelial necrosis and inhibition of nitric oxide synthase activity. Exp. Cell. Res. 230:1997;368-376.
17. Sutton E.T., Thomas T., Bryant M.W., Landon C.S., Newton C.A., Rhodin J.A.G. Amyloid-β peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1. J. Submicrosc. Cytol. Pathol. 31:1999;313-323.
18. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
19. Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B.S.S., Karoui H., Tordo P., Paitchard K.A. Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. USA. 95:1998;9220-9225.
20. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Moser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's diseases. Nature. 382:1996;685-691.
21. Yanker B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.